Calpain 15, also referred to as SOLH (sol homologue), is a member of the calpain family of calcium-dependent cysteine proteases. Calpains play crucial roles in various cellular processes, such as cytoskeletal remodeling, cell motility, signal transduction, and protein degradation. Calpain 15 shares the structural and functional characteristics typical of calpains, including the presence of EF-hand motifs, a conserved cysteine protease domain, and regulatory domains that respond to calcium. Inhibitors targeting Calpain 15 have been the subject of interest in biochemical research due to the enzyme's involvement in intricate cellular processes. These inhibitors typically act by blocking the active site of the enzyme or by modulating the conformational states required for its calcium-dependent activation, thus preventing proteolysis of target substrates.
The design of Calpain 15 inhibitors often involves specific modifications to peptide-like scaffolds or small molecules to improve selectivity and binding affinity. Structural analysis of Calpain 15 reveals that subtle differences in the protease domain compared to other calpains can be exploited to create more selective inhibitors. This selectivity is important to avoid off-target effects on other calpains, given their widespread cellular functions. Inhibitors are typically designed to mimic the structure of the enzyme's natural substrates or transition states, effectively competing for the active site. Additionally, non-peptidic small molecules have been explored for their ability to interact with regulatory domains of the enzyme, potentially offering alternative mechanisms of inhibition. These compounds can disrupt calcium binding or interfere with domain interactions necessary for the protease's function, offering valuable insights into calpain biochemistry.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | ¥1343.00 ¥5043.00 | 28 | |
Un inhibidor selectivo de la calpaína que se une al sitio activo de la enzima, obstruyendo el acceso del sustrato e inhibiendo así la actividad. | ||||||
MDL-28170 | 88191-84-8 | sc-201301 sc-201301A sc-201301B sc-201301C | 10 mg 50 mg 100 mg 500 mg | ¥767.00 ¥2663.00 ¥4942.00 ¥24279.00 | 20 | |
Un potente inhibidor de la calpaína permeable a las células que puede atravesar la barrera hematoencefálica, inhibiendo la proteasa al unirse a su sitio activo. | ||||||
PD 150606 | 179528-45-1 | sc-222133 sc-222133A | 5 mg 25 mg | ¥1309.00 ¥4456.00 | 18 | |
Un inhibidor que se une selectivamente a los sitios de unión del calcio en la calpaína, impidiendo su cambio conformacional necesario para la activación. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | ¥3103.00 ¥10470.00 ¥17408.00 | 14 | |
Un inhibidor irreversible que se une covalentemente al residuo de cisteína en el sitio activo de la calpaína, lo que produce una inhibición a largo plazo. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | ¥812.00 ¥1636.00 ¥2990.00 ¥5517.00 ¥15784.00 ¥1117.00 | 19 | |
Un inhibidor reversible que se dirige a los grupos tiol del sitio activo de las cisteína proteasas, impidiendo así la actividad de la calpaína. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | ¥632.00 ¥2933.00 ¥11056.00 | 163 | |
Un aldehído peptídico que inhibe la calpaína por interacción reversible con el sitio activo de la enzima. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | ¥1862.00 ¥6487.00 | 60 | |
Puede inhibir indirectamente la calpaína uniéndose irreversiblemente al proteasoma, lo que reduce la degradación de los inhibidores de la calpaína. | ||||||
MG-115 | 133407-86-0 | sc-221940 sc-221940A | 1 mg 5 mg | ¥982.00 ¥2482.00 | 3 | |
Inhibiteur aldéhyde peptidique qui entrave l'activité protéase de la calpaïne en se liant à son site actif. | ||||||